US to escalate tracking of COVID-19 variants as confirmed cases top 25 million

US to escalate tracking of COVID-19 variants as confirmed cases top 25 million

FILE PHOTO: Coronavirus vaccination site at NYCHA housing complex in Brooklyn
A pharmacist fills a syringe with the COVID-19 vaccine at a pop-up vaccination site in William Reid Apartments in Brooklyn, New York City, US, Jan 23, 2021. (Photo: Mary Altaffer/Pool via REUTERS)

WASHINGTON: The US Centers for Disease Control and Prevention is stepping up efforts to track coronavirus mutations and keep vaccines and treatments effective against new variants until collective immunity is reached, the agency's chief said on Sunday (Jan 24).

Dr Rochelle Walensky spoke about the rapidly evolving virus during a Fox News Sunday interview as the number of Americans known to have been infected surpassed 25 million, with more than 417,000 dead, just over a year after the first US case of COVID-19 was documented.

Walensky, who took over as CDC director the day President Joe Biden was sworn in, also said the greatest immediate culprit for sluggish vaccine distribution is a supply crunch worsened by inventory confusion inherited from the Trump administration.

READ: US COVID-19 vaccine supplies strain to meet wider eligibility, second doses

"The fact that we don't know today, five days into this administration, and weeks into planning, how much vaccine we have just gives you a sense of the challenges we've been left with," she told Fox News Sunday.

Biden's transition team was largely excluded from the government's vaccine rollout deliberations for weeks after his election as then-President Donald Trump refused to concede defeat and allow the incoming administration access to information needed to prepare to govern.

Ron Klain, Biden's chief of staff, said in a separate interview on NBC's Meet the Press that a plan for distributing the vaccine, particularly beyond nursing homes and hospitals, "did not really exist when we came into the White House".

Walensky said she was confident the government would soon resolve supply questions, and go on to dramatically expand vaccine production and distribution by late March.

Uncertainty over immediate supplies, however, will hinder efforts at the state and local levels to plan ahead for how many vaccination sites, personnel and appointments to set up in the meantime, exacerbating shortages in the short term, she said.

READ: Biden to impose COVID-19 travel ban on South Africa; reinstate curbs on visitors from UK, Europe and Brazil

RACE AGAINST VARIANTS

Vaccination has become ever more critical with the recent emergence of several coronavirus variants believed to be more transmissible, and in the case of one strain first detected in Britain, possibly more lethal.

"We are now scaling up both our surveillance of these and our study of these," Walensky said, adding that the CDC was collaborating with the National Institutes of Health, the Food and Drug Administration and even the Pentagon.

The object, she said, is to monitor "the impact of these variants on vaccines, as well as on our therapeutics", as the virus continues to mutate while it spreads.

Biden
Dr Rochelle Walensky, director of the US Centers for Disease Control and Prevention. (File photo: AP/Susan Walsh)

READ: New COVID-19 variants – Do the UK and South Africa virus strains pose a danger to Singapore?

Until vaccines can provide "herd" immunity in the population, mask-wearing and social distancing remain vital to "decrease the amount of virus that is circulating, and therefore, decrease the amount of variants that are out there", Walensky said.

Although British officials on Friday warned that the so-called UK variant of the coronavirus, already detected in at least 20 US states, was associated with a higher level of mortality, scientists have said existing vaccines still appeared to be effective against it.

They worry, however, that a more contagious South African variant may reduce the efficacy of current vaccines and shows resistance to three antibody therapeutics developed for treating COVID-19 patients.

Similarities between the South African variant and another identified in Brazil suggest the Brazilian variety may likewise resist antibody treatment.

READ: New COVID-19 variant defeats plasma treatment, may reduce vaccine efficacy

"We're in a race against these variants," said Vivek Murthy, nominated by Biden to become the next US surgeon general, on ABC's This Week program on Sunday.

Dr Anthony Fauci, the nation's leading infectious disease specialist, said in late December he was optimistic the United States could achieve enough collective immunity to COVID to regain "some semblance of normality" by the fall of 2021.

But Murthy said getting to herd immunity before a new school year begins in September was "an ambitious goal."

Nevertheless, Murthy suggested the government may exceed Biden's objective of administering 100 million vaccinations in the first 100 days of his presidency, telling ABC News, "that's a floor; it's not a ceiling".

Fauci, appearing separately on CBS News' Face the Nation, said the 100-million-shot goal encompasses people who may have received both injections of the two-dose vaccines and those who have only gotten the first jab.

About 21.8 million Americans, or about 6.5 per cent of the population, have received at least one dose of vaccine to date, of the 41.4 million doses shipped, CDC data showed on Sunday.

BOOKMARK THIS: Our comprehensive coverage of the coronavirus outbreak and its developments

Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus outbreak: https://cna.asia/telegram

Source: Reuters/dv

Bookmark